药理学和药物化学中的多目标药物的最新见解
在PubMed上查看摘要
概括
此摘要是机器生成的。多向药物设计为抗药性和治疗阿尔茨海默氏症和癌症等复杂疾病提供了有前途的方法. 这一策略涉及开发药物,同时吸引多个目标,以提高治疗效果.
科学领域
- 医学化学
- 药理学
- 药物发现
背景情况
- 目前的药物通常依赖于"特异性范式",导致获得耐药性和有效性降低.
- 复杂的疾病 (如阿尔茨海默病,帕金森病,癌症) 涉及多种遗传和环境因素,因此单一的目标方法是不够的.
- 具体性范式的局限性需要新的治疗策略.
研究的目的
- 审查多目标药物设计的方法.
- 探索多种药物的合成途径.
- 讨论多目标药物发现的应用和最新进展.
主要方法
- 建立和新兴多目标药物设计策略的概述.
- 分析多目标剂的化学反应和合成途径.
- 汇编了该领域的最新研究和案例研究.
主要成果
- 确定多目标药物开发的关键方法和合成方法.
- 证明多目标药物在克服耐药性的潜力.
- 突出多目标药物在复杂疾病中的适用性.
结论
- 多目标药物设计对于解决耐药性和复杂疾病至关重要.
- 与单一向药物相比,这种方法提供了更有效的治疗策略.
- 药物设计的持续研究有望在医学上取得重大进展.
相关概念视频
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

